These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 1970743)
21. Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male. O'Brien DP; Gale KM; Anderson JS; McVey JH; Miller GJ; Meade TW; Tuddenham EG Blood; 1991 Jul; 78(1):132-40. PubMed ID: 2070047 [TBL] [Abstract][Full Text] [Related]
22. Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factor. Chaing S; Clarke B; Sridhara S; Chu K; Friedman P; VanDusen W; Roberts HR; Blajchman M; Monroe DM; High KA Blood; 1994 Jun; 83(12):3524-35. PubMed ID: 8204879 [TBL] [Abstract][Full Text] [Related]
23. Establishment of a cell line expressing recombinant factor VII and its subsequent conversion to active form FVIIa through hepsin by genetic engineering method. Halabian R; Roudkenar MH; Esmaeili NS; Masroori N; Roushandeh AM; Najafabadi AJ Vox Sang; 2009 May; 96(4):309-15. PubMed ID: 19175565 [TBL] [Abstract][Full Text] [Related]
24. Characterization of a factor IX variant with a glycine207 to glutamic acid mutation. Lin SW; Lin CN; Hamaguchi N; Smith KJ; Shen MC Blood; 1994 Sep; 84(6):1866-73. PubMed ID: 7915915 [TBL] [Abstract][Full Text] [Related]
25. Severe factor VII deficiency caused by a novel mutation His348 to Gln in the catalytic domain. Katsumi A; Matsushita T; Yamazaki T; Sugiura I; Kojima T; Saito H Thromb Haemost; 2000 Feb; 83(2):239-43. PubMed ID: 10739380 [TBL] [Abstract][Full Text] [Related]
26. Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities. Husain SS Biochemistry; 1991 Jun; 30(23):5797-805. PubMed ID: 1828371 [TBL] [Abstract][Full Text] [Related]
27. Abnormal secretion and function of recombinant human factor VII as the result of modification to a calcium binding site caused by a 15-base pair insertion in the F7 gene. Peyvandi F; Carew JA; Perry DJ; Hunault M; Khanduri U; Perkins SJ; Mannucci PM; Bauer KA Blood; 2001 Feb; 97(4):960-5. PubMed ID: 11159523 [TBL] [Abstract][Full Text] [Related]
28. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla). Kemball-Cook G; Johnson DJ; Tuddenham EG; Harlos K J Struct Biol; 1999 Oct; 127(3):213-23. PubMed ID: 10544046 [TBL] [Abstract][Full Text] [Related]
29. Functional role of proteolytic cleavage at arginine-275 of human tissue plasminogen activator as assessed by site-directed mutagenesis. Tate KM; Higgins DL; Holmes WE; Winkler ME; Heyneker HL; Vehar GA Biochemistry; 1987 Jan; 26(2):338-43. PubMed ID: 3103680 [TBL] [Abstract][Full Text] [Related]
30. High-level production of human blood coagulation factors VII and XI using a new mammalian expression vector. Kemball-Cook G; Garner I; Imanaka Y; Nishimura T; O'Brien DP; Tuddenham EG; McVey JH Gene; 1994 Feb; 139(2):275-9. PubMed ID: 8112618 [TBL] [Abstract][Full Text] [Related]
31. Human alveolar macrophages synthesize factor VII in vitro. Possible role in interstitial lung disease. Chapman HA; Allen CL; Stone OL; Fair DS J Clin Invest; 1985 Jun; 75(6):2030-7. PubMed ID: 4008651 [TBL] [Abstract][Full Text] [Related]
32. Purification and properties of human coagulation factor VII. Broze GJ; Majerus PW J Biol Chem; 1980 Feb; 255(4):1242-7. PubMed ID: 7354023 [TBL] [Abstract][Full Text] [Related]
33. Autoactivation of human recombinant coagulation factor VII. Pedersen AH; Lund-Hansen T; Bisgaard-Frantzen H; Olsen F; Petersen LC Biochemistry; 1989 Nov; 28(24):9331-6. PubMed ID: 2611233 [TBL] [Abstract][Full Text] [Related]
34. Activation of bovine factor VII (proconvertin) by factor XIIa (activated Hageman factor). Kisiel W; Fujikawa K; Davie EW Biochemistry; 1977 Sep; 16(19):4189-94. PubMed ID: 901769 [TBL] [Abstract][Full Text] [Related]
35. Properties of a recombinant chimeric protein in which the gamma-carboxyglutamic acid and helical stack domains of human anticoagulant protein C are replaced by those of human coagulation factor VII. Geng JP; Castellino FJ Thromb Haemost; 1997 May; 77(5):926-33. PubMed ID: 9184404 [TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. Bajaj SP; Rapaport SI; Brown SF J Biol Chem; 1981 Jan; 256(1):253-9. PubMed ID: 6778860 [TBL] [Abstract][Full Text] [Related]
37. A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates. Toso R; Pinotti M; High KA; Pollak ES; Bernardi F Biochem J; 2002 Apr; 363(Pt 2):411-6. PubMed ID: 11931672 [TBL] [Abstract][Full Text] [Related]
38. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity. Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558 [TBL] [Abstract][Full Text] [Related]
39. Structure of human coagulation activated factor VII. Persson E Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S15-7. PubMed ID: 10850558 [TBL] [Abstract][Full Text] [Related]
40. Blood clotting factor IX Nagoya 3: the molecular defect of zymogen activation caused by an arginine-145 to histidine substitution. Suehiro K; Miyata T; Takeya H; Takamatsu J; Saito H; Murakawa M; Okamura T; Niho Y; Iwanaga S Thromb Res; 1990 Nov; 60(4):311-20. PubMed ID: 2087690 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]